|
Prospector Profile 07.1103
|
|
Repro-Med Systems, Inc. |
NAICS |
339100 |
24 Carpenter Road
Chester, NY 10918 |
Description |
Medical Equipment Mfg. |
(845) 469-2042 |
Employees |
20 |
http://www.repro-med.com/ |
Revenue |
(mil) |
1.7340 |
|
Income |
(mil) |
-0.2540 |
|
Assets |
(mil) |
1.1380 |
|
Liability |
(mil) |
1.7840 |
|
(for the year ended 2007-02-28) |
|
Category:
Audit Concerns
|
|
Event:
Meyler & Company LLC expressed doubts on the ability of Repro-Med Systems, Inc. to continue as a going concern after auditing its financial statements. Th auditor notes that the Company has an accumulated deficit of $3,427,011 and there are existing uncertain conditions the Company faces relative to its ability to obtain capital and operate successfully.
|
|
Intellectual Property:
On August 9, 2005, a patent was issued for a new mechanical variable flow rate controller. Used with its FREEDOM60® Syringe Infusion System, this device enables the user to select from a number of flow rates while using just one set of tubing, allowing flow rates to be changed during the course of a single infusion to better meet the needs of the patient. In June 10, 2003, the Company received a patent #6,575,946 for its new Full Stop Protection®. This addition to the RES-Q-VAC® system prevents any fluids from exiting the system. It also holds patent #5,336,189 for a "Combination IV Pump & Disposable Syringe" which confers a unique syringe to IV pump interface design. This patent is for the FREEDOM60® Infusion System, an infusion therapy product. [SEC Filing 10-KSB 06-04-07]
|
|
Description:
The Company is engaged in the design and manufacture of medical devices for medical respiratory products and infusion therapy worldwide.
|
|
Officers:
Andrew I. Sealfon (Chair, Pres., Treas. & CEO); Paul Mark Baker (Dir.); Nathan Blumberg (Dir.); Remo Spagnoli (Dir.)
|
|
Auditor:
Meyler & Company LLC
|
|
Securities:
Common Stock-Symbol REPR.OB; OTC BB;
29,012,286 common shares outstanding as of February 28, 2007.
|
|
|
|
return to main page |
|
|